English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduResoluteAI, the Connect to Discover™ company, today announced the launch of Nebula, its enterprise search solution for scientific organizations. Nebula tags and categorizes users’ content, connecting their proprietary information to ResoluteAI’s platform of comprehensive scientific databases.
Category: Marketplace
tellic gives scientists free access to AI tool that accelerates COVID-19 research
tellic, a technology startup based in New York, NY has been working for five years to develop an AI tool that surfaces actionable insights from biomedical research. Numerous biopharma currently use tellic graph as an AI-powered literature review tool to expedite their research.
FDA Approves New Total Wrist Replacement Device to Treat Painful Arthritis
The FDA has approved a new total wrist replacement device for people seeking relief from painful arthritis. The design is the culmination of three decades of award-winning research by Scott Wolfe, MD, a hand surgeon at Hospital for Special Surgery (HSS), and Joseph J. Crisco, III, PhD, director of the Bioengineering Laboratory at Brown University and Rhode Island Hospital.
From innovation to industry
A recently signed New Mexico law enables Sandia and Los Alamos national laboratories to assist in turning transferred technology into viable products and services, which could boost innovation and create jobs, according to Sandia business development experts.
Healthcare Communication Platform, Pulsara, Announces Release of FREE COVID-19 Management Package
Pulsara’s COVID-19 package enables networked communication (including HIPAA-compliant live video and messaging) across organizations at no charge.
Rapid Diagnosis Test for Coronavirus COVID-19 Now Available
Surgisphere Corporation announces the availability of a rapid diagnostic tool for novel coronavirus.
Smart Mouthguard Technology Licensed from University of Maryland, Baltimore
Technology for a smart mouthguard from the University of Maryland, Baltimore (UMB) has been licensed by University of Maryland School of Dentistry (UMSOD) alumnus Michael Wright, DDS, MS, into his new startup company, The WrightGuard Innovation Corporation.
Ceevra mobile 3D visualization platform adopted by renowned urologic oncology surgeon Dr. James Porter
Ceevra, Inc., a San Francisco-based advanced visualization platform for surgeons, today announced that renowned urologic oncology surgeon, Dr. James Porter, has commercially adopted Ceevra’s mobile 3D visualization platform to help plan and perform his kidney cancer operations.
Inspired by Patients, Laerdal Medical Brings Latest Simulator Advances to IMSH 2020
Healthcare professionals of all experience levels attend the IMSH conference to advance their skills, to impact change in their organizations, and, ultimately, to improve patient safety.
La Jolla Institute for Immunology acquires Berkeley Lights Beacon® platform
La Jolla Institute for Immunology (LJI) is placing their confidence in Berkeley Lights’ Beacon® Optofluidic Platform and B cell antibody discovery workflow to accelerate the discovery of rare and lifesaving antibodies for the treatment of re-emerging and emerging diseases.
CROP INNOVATION COMPANY INTRODUCES NEW SEED COMPANY FOCUSED ON HIGH-PERFORMANCE FOOD & FEED GRADE SOYBEANS
Benson Hill today announced the launch of Benson Hill Seeds, a business focused on delivering superior seeds to meet the evolving needs of the growing human food and animal feed markets, including the eMerge Genetics portfolio of non-GMO soybean varieties.
ACADEMY OF NUTRITION AND DIETETICS INTRODUCES NEW BOOK BY WORLD-RENOWNED WEIGHT MANAGEMENT EXPERT
The Academy of Nutrition and Dietetics has announced the publication of its new book, Six Factors to Fit: Weight Loss that Works for You!, which tailors weight loss plans to fit each person’s lifestyle, habits and mindset.
MimiVax LLC and Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. announce exclusive licensing agreement on SurVaxM for glioblastoma treatment in China
Buffalo-based clinical-stage biotechnology company MimiVax, a Roswell Park Comprehensive Cancer Center spinoff, set to work with leading healthcare group in China to provide promising immunotherapy
University of Adelaide to widen scope of education through online learning
The University of Adelaide will educate thousands of additional students online over the next five years, thanks to a new partnership with the world’s leading learning company, Pearson.
Los Alamos National Laboratory teams with Arm to develop tailored, efficient processor architectures for extreme-scale computing
Los Alamos National Laboratory and Arm are teaming up to make efficient, workload-optimized processors tailored to the extreme-scale computing requirements of the Laboratory’s national-security mission.
AUTOIMMUNE ASSOCIATION ANNOUNCES 2019 LA WALK
Grammy® Nominated Songwriter and Singer Dayna Caddell to Lead 5th Annual Los Angeles Autoimmune Walk on November 3. Former NFL Dallas Cowboys Player Darryl Clack is the Featured Speaker. The Walk is part of AARDA’s “Linking Together for a Cure” campaign to raise awareness and funding for research.
Mount Sinai and Brooklyn Cyclones Team-Up for “Mount Sinai Brooklyn Day” at MCU Park in Coney Island
Mount Sinai Brooklyn is a Proud Sponsor of the Brooklyn Cyclones
PREMIUM WINE & SPIRITS DISTRIBUTOR PARTNERS TO PREVENT COUNTERFEIT ALCOHOL
Incidents related to methanol and counterfeit alcohol are increasing around the world. A leading international Wine & Spirits distributor is taking proactive steps to promote awareness and insure their popular liquor and wine brands are authentic and safe.
PREMIUM WINE & SPIRITS DISTRIBUTOR PARTNERS TO PREVENT COUNTERFEIT ALCOHOL
Incidents related to methanol and counterfeit alcohol are increasing around the world. A leading international Wine & Spirits distributor is taking proactive steps to promote awareness and insure their popular liquor and wine brands are authentic and safe.
JOGO HEALTH to present evidence of digital therapeutics at ANZSCoS Annual Scientific Meeting
JOGOHEALTH Inc., a privately held digital therapeutics company focused on the development and commercialization of treatments for neuromuscular (NM) conditions such as stroke, spinal cord injury, cerebral palsy and urinary incontinence today announced that it will present evidence and performance of its lead investigational product JOGO, at the 2019 Australian & New Zealand Spinal Cord Society (ANZSCoS) Annual Scientific Meeting held at Pullman Melbourne Albert Park in Melbourne, Australia from 21 – 23 August 2019.
MyoKardia Launches 2nd Annual MyoSeeds™ Research Grants Program to Advance Independent Research in Heart Disease
MyoKardia, Inc. today announced the launch of the 2nd Annual MyoSeeds™ Research Grants Program, an initiative to support original, independent research in the biology and underlying mechanisms of cardiomyopathies and precision heart disease treatment.
Beckman Coulter MicroScan Wins IMV ServiceTrak™ Best System Performance for the Second Year in a Row
Beckman Coulter MicroScan Wins IMV ServiceTrak™ Best System Performance for the Second Year in a Row
Quest Diagnostics Now Participating in NCI-MATCH Precision Medicine Clinical Trial
As the leader in Advanced Diagnostics, including Next Generation Sequencing (NGS), Quest joins a select group of commercial and academic laboratories to meet the rigorous requirements for participation in this clinical trial.
Both the Quest Med Fusion 50SEQ cancer panel and IBM Watson Genomics from Quest Diagnostics service fulfill the trial’s criteria for accuracy and reliability in tumor profiling.
Quest Diagnostics to accelerate cardiovascular disease biomarker discovery as part of One Brave Idea™ initiative to end coronary heart disease
The power of healthcare data gives rise to novel markers of cardiovascular disease and stroke in the earliest, preventable stages
Data Innovations Partners with STS Rules Verification Testing to Accelerate Laboratory Autoverification
Data Innovations (DI) and STS announced a strategic partnership to deliver automated and intelligent rules verification testing for Data Innovations’ industry-leading Autoverification solution from their flagship lab enablement platform, Instrument Manager.
Quest Diagnostics to Showcase New Data at the American Heart Association 2018 Scientific Sessions
New Findings Demonstrate the Benefit of Using Genetic Markers to Aid Detection of Atrial Fibrillation
Research is a Product of Quest’s First National Cardiovascular Center of Excellence Based at Cleveland HeartLab
Lab Enablement Leadership as Data Innovations Celebrates 30th Anniversary
Lab enablement solutions industry leader, Data Innovations, celebrates their 30th anniversary. Founded as the lab industry’s first Connectivity provider with its flagship solution, Data Innovations has continued to evolve as the clinical lab’s go-to technology platform for lab optimization, standardization, and workflow automation.
Workforce Drug Testing Positivity Climbs to Highest Rate Since 2004, According to New Quest Diagnostics Analysis
Analysis of more than ten million workplace drug test results shows increases in marijuana positivity across nearly all employee testing categories.
Increases in post-accident positivity in the general U.S. workforce outpace those for all other testing reasons, including pre-employment screening
Quest Diagnostics to Present New Insights from Genetic Testing at the 2019 Annual American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting
Eight presentations highlight Quest’s Advanced Diagnostics testing and research insights into hereditary genetics.
Quest Diagnostics Welcomes New Members to the Global Diagnostics Network (GDN)
Two new companies join the GDN, expanding this novel worldwide network of leading diagnostics service providers. With nine members spanning the globe, the GDN has a presence in countries covering two-thirds of the world’s population, and over 90% of the global pharmaceutical market
Siemens Healthineers to Showcase the Power of Data in the Lab with its Atellica Diagnostics IT Solutions at AACC 2019
At the 71st AACC Annual Scientific Meeting & Clinical Lab Expo, Siemens Healthineers will feature in Booth #1039 its innovative IT solutions to combat the laboratory’s staffing challenges, limited budgets, and the increasing complexity in sample management and testing.
Worthington Announces Release of New Product Catalog at American Association for Clinical Chemistry
A new digital catalog for a new generation of life science, pre-clinical and bulk OEM/bioprocessing researchers. This new catalog highlights enzymes and related biochemicals for classical and molecular diagnostics, biochemistry, bioprocessing and pre-clinical research applications.
Randox QC unveils brand new multi-analyte commutable Acusera Infectious Disease Controls
Randox Quality Control is set to introduce its brand new Acusera Infectious Disease (Serology) Controls at the American Association for Clinical Chemistry 2019.
On display at AACC 2019: How Advanced Instruments Gets – and Keeps – Your Lab Up and Running
Advanced Instruments,booth #1361, at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim, CA, August 4-8, 2019.
PixCell’s Viscoelastic Focusing Technology Shifts the Paradigm in Hematology Point of Care Accessibility
Pixcell’s HemoScreen™ is a portable cartridge-based platform. It is fast, simple to use, and a cost-effective means of providing crucial diagnostic information, near patient, where it is needed most.
Vanderbilt University Medical Center Completes Acquisition of Tennova Healthcare-Lebanon
Leaders of Vanderbilt University Medical Center (VUMC) today announced completion of the acquisition of Tennova Healthcare-Lebanon, a two-campus facility licensed for 245 beds, from subsidiaries of Community Health Systems, Inc. (CHS). Terms of the transaction will remain confidential.
Ins. For Renascence to Exhibit at AACC Annual Scientific Meeting & Clinical Lab Expo 2019 at Booth #672
Ins. For Renascence, a big data company focusing on insurance risk control, is committed to creating industry-level intelligence solutions, will exhibit their plans to attend the upcoming 71st American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo in Anaheim, California from August 6-8. The company will use the time at the show to highlight its research developments.
StaffReady® Offers Document Control Software for the Healthcare Industry
StaffReady Offers Document Control Software for the Healthcare Industry
Multiplex biochip for accurate differentiation of stroke types launched at AACC
A ground-breaking new test which improves the accuracy of stroke diagnosis has been developed by Randox scientists.
H-FABP for Acute Kidney Injury testing revealed by Randox
A new testing application for the biomarker Heart-Type Fatty Acid-Binding Protein (H-FABP) has been revealed by global diagnostics company Randox Laboratories.
Whilst H-FABP is most commonly recognized as an early biomarker of myocardial infarction, the assay’s clinical utility in cardiac surgery associated acute kidney injury (CSA-AKI) is notable.
High-Performance Plasma Separator Media is designed to optimize small-sample diagnostic device performance.
The new D 23 TC1® plasma separation media from I.W. Tremont delivers high yield, optically clear plasma from whole blood. Ideal for applications used in diagnostic devices where rapid conversion is required from small sample volumes (5-20 µl).
Mesa Biotech to Present Comparative Flu & RSV Detection Analysis with Other FDA-Cleared Molecular Assays at the AACC Annual Scientific Meeting Lecture Series
Stephen Young, PhD, Director of Research and Clinical Trials at TriCore Reference Laboratory will present performance comparisons of the Accula visually read PCR testing platform with other FDA-cleared molecular tests for influenza A/B and respiratory syncytial virus (RSV) assays. The lecture will take place on August 6, 2019 at 1:00 pm in theater 3 of the exhibit hall at AACC.
Mesa Biotech to Present Comparative Flu & RSV Detection Analysis with Other FDA-Cleared Molecular Assays at the AACC Annual Scientific Meeting Lecture Series
Stephen Young, PhD, Director of Research and Clinical Trials at TriCore Reference Laboratory will present performance comparisons of the Accula visually read PCR testing platform with other FDA-cleared molecular tests for influenza A/B and respiratory syncytial virus (RSV) assays. The lecture will take place on August 6, 2019 at 1:00 pm in theater 3 of the exhibit hall at AACC.
Randox launches whole pathogen Blood Borne Virus Controls at AACC
Whole pathogen Blood Borne Virus (BBV) controls have been brought to market by global diagnostics company Randox Laboratories.
Web Industries showcases automated manufacturing solutions for LFI and medical diagnostic devices at AACC 2019
Medical device OEMs in search of commercialization and manufacturing solutions for lateral flow immunization (LFI) and medical diagnostic devices will discover several new capabilities and services that virtually eliminate product variability, improve overall quality and lower costs from contract manufacturer (CMO) Web Industries at AACC 2019, August 4 – 8, Anaheim Convention Center.
Festo Demonstrates Laboratory-Medicine Automation Innovations at AACC 2019
At AACC, Festo introduces a 96-head bulk dispenser which will be used for speeding up sample handling. Festo continues to innovate in the liquid dispensing and automated sample handling arena.
Mesa Biotech to Launch Molecular, Sample-to-Answer RSV Test at the 2019 AACC Annual Scientific Meeting
Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable, sample-to-answer, CLIA-waived PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease diagnosis, today announced the launch of its respiratory syncytial virus test (RSV). Mesa will demonstrate its expanded, novel Accula™ Test System at the 71st American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo. The Accula System’s RSV and Flu A/Flu B molecular tests will be on exhibit in Booth 3902. Sekisui Diagnostics distributes both products in the US under the Silaris™ brand.
Web Industries showcases automated manufacturing solutions for LFI and medical diagnostic devices at AACC 2019
MARLBOROUGH, Mass. – July 25, 2019 – Medical device OEMs in search of commercialization and manufacturing solutions for lateral flow immunization (LFI) and medical diagnostic devices will discover several new capabilities and services that virtually eliminate product variability, improve overall quality and lower costs from contract manufacturer (CMO) Web Industries at AACC 2019, August 4 – 8, Anaheim Convention Center.
Shaping the future of Diagnostics through MULTIPLEXING and SINGLE CELL approach
This year, SCIENION and cellenion will organize a yearly wkrshop in Lyon, from 3rd to 4th of September.
STRATEC enters the module business and strengthens its platform business with the new chemiluminescence platform KleeYa
STRATEC takes a further step towards the diversification of its product portfolio by introducing stand-alone modules and a new chemiluminescence immunoassay platform as adjuncts to its core business- the development and manufacturing of OEM instrumentation.